4Blackstein M,Vogel CL,Ambinder R,et al.Gemcetabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trail[J].Oncology,2002,62(1):2-8.
5Heinemann V.Gemcitabline plus cisplatin for the treatment of metastatic breast cancer[J].Clin Breast Cancer,2002,62(1):2-8.
6Tripathy D.Overview:Gemcitabine as single-agent therapy for advanced breast cancer[J].Clin Breast Cancer,2002,3(Suppl 1):8-11.
7Seidman AD.Gemcitabine as single-agent therapy in the management of advanced breast cancer[J].Oncology,2001,15(2) (Suppl 3):11-14.
8Mohran TZ.Gemcitabine and Cisplatin combination chemotherapy as a first-line treatment in patients with metastatic breast cance[J].J Egypt Nat1 Canc Inst.2004,16(1):8-14.
9Nagourney RA,Link JS,Blitzer J,et al.Gemcitabline plus cisplatin repeating doublet therapy in previously treated,relapsed breast cancer patients[J].J Clin Oncol,2000,18(11):224-2249.
2Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J C1in,2011,61 ( 2 ) :69 - 90.
3Nagourney RA, Link JS, Blitzer J, et al. Gemcitabine plus cisplatin repeating double therapy in previously treated relapsed breast cancer patients [ J ]. J Clin 0ncol,2000, 18 ( 1 ) : 2245 - 2249.
4Higgins JP T, Green S. Coehrane Handbook 5. 1. for systematic reviews of interventions [ A ]. Cochrane Library [ M ]. Issue 4. Chichester: John Wiley, 2011 : 83 - 84.
